首頁 > 市場調查報告書 > 製藥

醫藥品原料藥

市場調查報告書

商品編碼

1935378

小分子原料藥市場：依原料藥類型、應用與地區分類

Small Molecule API Market, By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

出版日期: 2026年01月21日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，小分子原料藥市場規模將達到 1,304 億美元，到 2033 年將達到 1,774 億美元，2026 年至 2033 年的複合年成長率為 4.5%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	1304億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	4.50%	2033 年的預測值：	1774億美元

小分子活性藥物成分（API）是分子量較低的有機化合物，可能有助於調節生物過程。大多數小分子化合物可口服給藥，且容易被人體吸收。其小分子尺寸使其能夠快速擴散並到達細胞內的作用位點。

市場動態

亞太地區小分子原料藥生產商的擴張是推動小分子原料藥市場成長的主要因素。例如，BASF計劃在其位於中國南京化工園區的現有廠址新建一座特種胺工廠。這座新的多產品工廠年產能將達到2.1萬噸胺類化合物，並將擴大BASF南京特種胺生產基地的胺類產品組合。該工廠預計將於2019年運作。此外，隨著全球銷售和業務拓展部門的擴張，小分子原料藥生產商計劃擴充其品管、法規事務和計劃管理團隊，這也將對市場成長產生積極影響。

然而，嚴格的原料藥生產監管政策可能會阻礙市場成長。全球範圍內針對小分子原料藥生產品質評估、設施認證以及新興國家日益嚴峻的供應鏈安全問題的嚴格監管政策，顯著影響了最終小分子原料藥產品的成本。由於上述因素，有意進入小原料藥生產市場的新企業面臨巨大的財務挑戰。

本次調查的主要特點

本報告對小分子原料藥市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）內的市場規模（十億美元）和復合年成長率（%）。
我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、影響分析、PEST 分析、合作關係、併購、監管環境、技術進步、小分子 API 的生產流程、主要供應商和市場趨勢的關鍵見解。
該研究根據以下參數對全球小分子API市場的主要企業進行了分析：公司概況、財務業績、產品系列、市場地位、分銷策略、關鍵發展、戰略和未來計劃。
本報告的研究結果將使負責人和企業經營團隊能夠就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球小分子原料藥市場報告的目標受眾是業內各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析小分子原料藥市場的策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- ALLERGAN
- Aurobindo Pharma
- Cambrex Corporation
- Albemarle Corporation
- Dr Reddy's Laboratories Ltd.
- Johnson Matthey
- Siegfried Holding AG
- Pfizer
- Sanofi SA
- Novartis AG
- Johnson &Johnson
- Bristol-Myers Squibb
- Bachem Holding AG
- Boehringer Ingelheim GmbH
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- GILEAD Science Inc.
- Albany Molecular Research Inc.
- Sun Pharmaceuticals
- AstraZeneca
- Merck &Co, Inc.
- BASF SE
- Teva Pharmaceuticals

第8章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第9章各節

參考
調查方法

簡介目錄

Product Code: CMI2423

Small Molecule Api Market is estimated to be valued at USD 130.4 Bn in 2026 and is expected to reach USD 177.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 130.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.50%	2033 Value Projection:	USD 177.4 Bn

A small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach the intracellular site of action.

Market Dynamics

Growing expansion of small molecule API manufacturers in the Asia Pacific region is a major factor driving the small molecule API market growth. For instance, BASF is planning to build a new specialty amines plant at its existing site in Nanjing Chemical Industry Park, China. This new multi-product plant will be able to manufacture 21,000 metric tons of amines year, and it extends BASF's amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to stream by 2019. Moreover the small molecule API manufacturers have planned to add global sales and business development staff, followed by quality, regulatory, and project management teams, which have positively influenced growth of the market.

However, stringent regulatory policies for API manufacturing may hinder the market growth. Stringent global regulatory policies on quality assessments of small molecule API manufacturing, facility certification, and increased supply chain security issues across emerging countries have a large impact on the cost of final small molecule API products. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges, owing to aforementioned factors.

Key features of the study

This report provides in-depth analysis of the small molecule API market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, impact analysis, PEST analysis, collaborations, mergers and acquisitions, regulatory scenarios, technological advancements, steps to manufacture small molecule API, major suppliers of small molecule APIs, market trends
It profiles key players in the global small molecule API market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc, Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, CordenPharma International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global small molecule API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the small molecule API market

Market Segmentation

API Type Insights (Revenue, USD Bn, 2026 - 2033)
- Synthetic
- Biological
Application Insights (Revenue, USD Bn, 2026 - 2033)
- Oncology
- Neurology
- Metabolic
- Infectious
- Cardiovascular
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- ALLERGAN
- Aurobindo Pharma
- Cambrex Corporation
- Albemarle Corporation
- dr. Reddy's Laboratories Ltd.
- Johnson Matthey
- Siegfried Holding AG
- Pfizer
- Sanofi S.A.
- Novartis AG
- Johnson & Johnson
- Bristol-Myers Squibb
- Bachem Holding AG
- Boehringer Ingelheim GmbH
- Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- GILEAD Science Inc.
- Albany Molecular Research Inc.
- Sun Pharmaceuticals
- AstraZeneca
- Merck & Co, Inc.
- BASF SE
- Teva Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By API Type
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Small Molecule API Market, By API Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Synthetic
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Biological
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Small Molecule API Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Neurology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Metabolic
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cardiovascular
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Small Molecule API Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- ALLERGAN
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Aurobindo Pharma
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cambrex Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Albemarle Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- D.r. Reddy's Laboratories Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson Matthey
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Siegfried Holding AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Pfizer
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sanofi S.A.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novartis AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson & Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bristol-Myers Squibb
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bachem Holding AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GlaxoSmithKline PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GILEAD Science Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Albany Molecular Research Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sun Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- AstraZeneca
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Merck & Co, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- BASF SE
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Teva Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

8. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

小分子原料藥市場規模、佔有率及成長分析（按類型、製造商、應用及地區分類）－2026-2033年產業預測

小分子 API 市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

合成小分子 API 市場規模、佔有率、趨勢分析報告：按製造商、應用、地區、細分市場預測，2025-2030 年

小分子 API 市場規模、佔有率、趨勢分析報告：按類型、製造商、應用程式、地區、細分市場、預測，2025-2030 年

小分子 API 連續製造市場規模、佔有率、趨勢分析報告：按設備、按單元操作、按類型、按最終用途、按地區、細分市場預測，2024-2030 年

FAQ

小分子原料藥市場：依原料藥類型、應用與地區分類

Small Molecule API Market, By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

市場動態